regulatory
confidence high
sentiment negative
materiality 0.60
Coeptis Therapeutics receives Nasdaq delisting notice for missing annual meeting; meeting set for Jan 30
Z Squared Inc.
- Nasdaq letter on Jan 12, 2026 cites violation of Listing Rules 5620(a) and 5810(c)(2)(G) for failing to hold annual meeting within 12 months of fiscal year end (Dec 31, 2024).
- Company has 45 days to submit compliance plan; if accepted, Nasdaq may grant exception until June 29, 2026.
- Annual meeting scheduled for January 30, 2026, which Coeptis believes will cure the deficiency.
- Ticker: COEP (Nasdaq); warrants trade as COEPW.